Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > Management changes at Niogold

<< Previous

Bullboard Posts

Next >>

Post by MrMonkon Mar 23, 2015 8:21am

119 Views

Post# 23550049

Management changes at Niogold

Niogold has recruited two new people to its management team - both formerly with Osisko. They appear to be loading up on former Osisko people - you can interpret that in your own way. I have my views.

Official news release should come out this morning.

-- MM

<< Previous

Bullboard Posts

Next >>

Canadian psychedelic stock to supply MDMA to Yale